Cargando…

Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs

BACKGROUND: Although both nonfunctional paraganglioma of the bladder (NPB) and urothelial carcinoma of the bladder (UCB) are subtypes of bladder tumors, they are entirely different entities with distinct tissue origins and anatomical locations. However, NPB is frequently misdiagnosed as UCB chiefly...

Descripción completa

Detalles Bibliográficos
Autores principales: Male, Musa, Ye, Tao, Tao, Jin, Chen, Zhi-qiang, Peng, Ejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874976/
https://www.ncbi.nlm.nih.gov/pubmed/31781590
http://dx.doi.org/10.1155/2019/1097149
_version_ 1783472926183391232
author Male, Musa
Ye, Tao
Tao, Jin
Chen, Zhi-qiang
Peng, Ejun
author_facet Male, Musa
Ye, Tao
Tao, Jin
Chen, Zhi-qiang
Peng, Ejun
author_sort Male, Musa
collection PubMed
description BACKGROUND: Although both nonfunctional paraganglioma of the bladder (NPB) and urothelial carcinoma of the bladder (UCB) are subtypes of bladder tumors, they are entirely different entities with distinct tissue origins and anatomical locations. However, NPB is frequently misdiagnosed as UCB chiefly due to the similarities in their clinical characteristics and cystoscopic features. This study aimed to compare the differences in their clinical characteristics and cystoscopic features. PATIENTS AND METHODS: Between April 2007 and September 2017, 14 patients with NPB (NPB group) were retrieved from 2 centers, and 42 patients with new-onset UCB (UCB group) were randomly retrieved. Demographic, symptomatic, imaging, and cystoscopic data of patients in both groups were collected and compared. RESULTS: NPB group comprised 7 males and 7 females, with a mean age of 43.1 ± 13.6 years. Compared with the UCB group, patients in the NPB group were significantly younger (p < 0.001), less likely to be male (p < 0.05), and to present with hematuria (p < 0.01). However, no significant difference in maximum tumor diameter was observed between the 2 groups (p=0.609). Compared with the UCB group, cystoscopically, patients in the NPB group were significantly more likely to present with hypervascularization but less likely to present with hemorrhage, necrosis, calcification, pedunculation, and multilesion (p < 0.05). No patients with NPB were clinically diagnosed correctly before cystoscopy. Of the 5 patients who underwent both cystoscopy and biopsy, 4 were diagnosed with NPB, while 1 remained undiagnosed. Of the remaining 9 patients who underwent cystoscopy only, 5 were diagnosed with nonepithelial tumor, and 4 were misdiagnosed with UCB. CONCLUSIONS: Age, sex, and hematuria may provide clues to differentiating NPB from UCB. Differences in cystoscopic features between NPB and UCB are of high diagnostic value. Cystoscopic biopsy should be considered in the preoperative diagnosis of NPB.
format Online
Article
Text
id pubmed-6874976
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-68749762019-11-28 Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs Male, Musa Ye, Tao Tao, Jin Chen, Zhi-qiang Peng, Ejun Biomed Res Int Research Article BACKGROUND: Although both nonfunctional paraganglioma of the bladder (NPB) and urothelial carcinoma of the bladder (UCB) are subtypes of bladder tumors, they are entirely different entities with distinct tissue origins and anatomical locations. However, NPB is frequently misdiagnosed as UCB chiefly due to the similarities in their clinical characteristics and cystoscopic features. This study aimed to compare the differences in their clinical characteristics and cystoscopic features. PATIENTS AND METHODS: Between April 2007 and September 2017, 14 patients with NPB (NPB group) were retrieved from 2 centers, and 42 patients with new-onset UCB (UCB group) were randomly retrieved. Demographic, symptomatic, imaging, and cystoscopic data of patients in both groups were collected and compared. RESULTS: NPB group comprised 7 males and 7 females, with a mean age of 43.1 ± 13.6 years. Compared with the UCB group, patients in the NPB group were significantly younger (p < 0.001), less likely to be male (p < 0.05), and to present with hematuria (p < 0.01). However, no significant difference in maximum tumor diameter was observed between the 2 groups (p=0.609). Compared with the UCB group, cystoscopically, patients in the NPB group were significantly more likely to present with hypervascularization but less likely to present with hemorrhage, necrosis, calcification, pedunculation, and multilesion (p < 0.05). No patients with NPB were clinically diagnosed correctly before cystoscopy. Of the 5 patients who underwent both cystoscopy and biopsy, 4 were diagnosed with NPB, while 1 remained undiagnosed. Of the remaining 9 patients who underwent cystoscopy only, 5 were diagnosed with nonepithelial tumor, and 4 were misdiagnosed with UCB. CONCLUSIONS: Age, sex, and hematuria may provide clues to differentiating NPB from UCB. Differences in cystoscopic features between NPB and UCB are of high diagnostic value. Cystoscopic biopsy should be considered in the preoperative diagnosis of NPB. Hindawi 2019-11-06 /pmc/articles/PMC6874976/ /pubmed/31781590 http://dx.doi.org/10.1155/2019/1097149 Text en Copyright © 2019 Musa Male et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Male, Musa
Ye, Tao
Tao, Jin
Chen, Zhi-qiang
Peng, Ejun
Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title_full Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title_fullStr Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title_full_unstemmed Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title_short Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
title_sort differentiating nonfunctional paraganglioma of the bladder from urothelial carcinoma of the bladder: pitfalls and breakthroughs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874976/
https://www.ncbi.nlm.nih.gov/pubmed/31781590
http://dx.doi.org/10.1155/2019/1097149
work_keys_str_mv AT malemusa differentiatingnonfunctionalparagangliomaofthebladderfromurothelialcarcinomaofthebladderpitfallsandbreakthroughs
AT yetao differentiatingnonfunctionalparagangliomaofthebladderfromurothelialcarcinomaofthebladderpitfallsandbreakthroughs
AT taojin differentiatingnonfunctionalparagangliomaofthebladderfromurothelialcarcinomaofthebladderpitfallsandbreakthroughs
AT chenzhiqiang differentiatingnonfunctionalparagangliomaofthebladderfromurothelialcarcinomaofthebladderpitfallsandbreakthroughs
AT pengejun differentiatingnonfunctionalparagangliomaofthebladderfromurothelialcarcinomaofthebladderpitfallsandbreakthroughs